DataExpo GAKG DeepReport Navigation

Copyright©2015-2024 Acemap, Inc. Shanghai Jiao Tong University. All rights reserved.

沪ICP备18028330号

EH

E.J. Heathcote

University of Toronto

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

Patrick Marcellin

Hôpital Beaujon

Jane Anderson

Homerton University Hospital

Elsa Mondou

Bioscience Research

J. Sorbel

Gilead Sciences (United States)

Franck Rousseau

Banner Life Sciences (United States)

Stefan Zeuzem

Goethe University Frankfurt

Ira M. Jacobson

NYU Langone Health

Geoffrey Dusheiko

University College London

Philippe Mathurin

Hôpital Claude Huriez

Marı́a Buti

Vall d'Hebron Hospital Universitari

Cooperative Institutions

University of Toronto

University Health Network

Toronto General Hospital

Gilead Sciences (United States)

Erasmus MC

Inserm

Toronto Western Hospital

Erasmus University Rotterdam

University of Oxford

Goethe University Frankfurt

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

1006 HBSAG KINETICS OF DECAY AND BASELINE CHARACTERISTICS OF HBEAG-POSITIVE PATIENTS WITH CHRONIC HEPATITIS B FOLLOWING 3 YEARS OF TENOFOVIR DISOPROXIL FUMARATE (TDF) TREATMENT

Journal of Hepatology (2010)

E. Gane E.J. Heathcote Patrick Marcellin Geoffrey Dusheiko Ira M. Jacobson

Tenofovir

HBeAg

10.1016/s0168-8278(10)61007-0

Cite

Citations (12)

611 Poor prognostic factors in heavier patients with chronic hepatitis C (CHC) result in less favourable treatment outcomes

Journal of Hepatology (2006)

Mark G. Swain Graham R. Foster S.J. Hadzivannis E.J. Heathcote Dorte M. Jensen

10.1016/s0168-8278(06)80611-2

Cite

Citations (3)

20 THREE YEARS OF TENOFOVIR DISOPROXIL FUMARATE (TDF) TREATMENT IN HBEAG-NEGATIVE AND POSITIVE PATIENTS WITH CHRONIC HEPATITIS B (STUDY 102 AND STUDY 103)

Digestive and Liver Disease (2010)

Mario Rizzetto Patrick Marcellin E.J. Heathcote J. Sorbel Elsa Mondou

Tenofovir

HBeAg

10.1016/s1590-8658(10)60390-8

Cite

Citations (1)

925 SAFETY AND TOLERABILITY OF 96 WEEKS OF TENOFOVIR DISOPROXIL FUMARATE (TDF) TREATMENT IN HBeAg NEGATIVE AND POSITIVE PATIENTS INFECTED WITH CHRONIC HEPATITIS B (CHB)

Journal of Hepatology (2009)

Patrick Marcellin E.J. Heathcote Ira M. Jacobson Philippe Mathurin Edward Gane

Tenofovir

Tolerability

HBeAg

10.1016/s0168-8278(09)60927-2

Cite

Citations (1)

54 PRESENCE OF ONLY WILDTYPE VIRUS IS THE STRONGEST DETERMINANT OF HBVDNA UNDETECTABILITY AND HBSAG CLEARANCE IN HBEAG-POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON

Journal of Hepatology (2012)

Milan J. Sonneveld Vincent Rijckborst Stefan Zeuzem E.J. Heathcote Krzysztof Simon

HBeAg

10.1016/s0168-8278(12)60068-3

Cite

Citations (0)

Is the mayo model useful for predicting survival following the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?

Gastroenterology (1995)

M.R. Kilmurry Karen Cauch‐Dudek Kacey O’Rourke E.J. Heathcote

Ursodeoxycholic acid

Primary Biliary Cirrhosis

Primary (astronomy)

Biliary cirrhosis

10.1016/0016-5085(95)28689-6

Cite

Citations (4)

656 HIGH PREVALENCE OF FATIGUE IN PATIENTS WITH SCLEROSING CHOLANGITIS

Journal of Hepatology (2009)

Nadya Al‐Harthy Teru Kumagi S. Parasar Catalina Coltescu E.J. Heathcote

Apgar score

Medical record

10.1016/s0168-8278(09)60658-9

Cite

Citations (5)

Histopathology of cocaine hepatotoxicity

Gastroenterology (1990)

Ian R. Wanless Sylvain Doré N Gopinath Jensen C. C. Tan Ross Cameron

Histopathology

Acetaminophen

Steatosis

Azotemia

Acute tubular necrosis

10.1016/0016-5085(90)90845-r

Cite

Citations (145)

Reduced bone mineral density derived from dual X-ray absorptiometry assessments in lamivudine experienced patients with chronic hepatitis B (CHB).

S. Fung Milotka Fabri E.J. Heathcote Selım Gürel W.C.P. Kwan

Hepatitis B

Cite

Citations (0)

A randomised double-blind phase II study of lamivudine (LAM) compared to lamivudine plus adefovir dipovoxil (ADV) for treatment naïve patients with chronic hepatitis B (CHB): Week 52 analysis

Journal of Hepatology (2003)

Joseph J.�Y. Sung Junmei Lai Stefan Zeuzem W.C. Chow E.J. Heathcote

Adefovir

10.1016/s0168-8278(03)80485-3

Cite

Citations (82)